Typical side effects of Abilify in child: shaking, sleepiness, sweating, seizures, suicidal thoughts, stomach pain, slurred speech, shortness of breath, swelling.
Abilify, clinically called aripiprazole, is a medication used to treat schizophrenia, bipolar affective disorder and depression. Abilify wased initially authorized by the U.S. Food and Drug Administration in 2002 and has been studied extensively relating to efficiency and adverse side effects. It regulates dopamine and serotonin levels in brain. Abilify can have various side effects depending on the condition that it was recommended for. Children do not have a completely established blood-brain barrier, and therefore, neuroleptics such as Abilify can cause a various range of side effects compared with adult patients.
Sleep and Energy Problems
In the October 2007 problem of “Schizophrenia Bulletin,” Dr. Sanjiv Kumra and associates discovered that somnolence and fatigue are the first and 3rd most frequently reported side effects in children taking Abilify. Somnolence refers to the state of being drowsy or the strong desire to sleep and happened in as much as 23 percent of children taking Abilify. Fatigue is the sense of feeling weak, worn out and low energy and occurs in around 11 percent of children taking Abilify. According to Abilify.com, children also frequently experience insomnia, sedation and other sleep-wake related side effects. Medications used to manage the neurotransmitters dopamine and serotonin typically produce side effects that disrupt sleep and energy levels. Parents can help their children decrease these side effects by providing a consistently healthy diet and a routine workout routine.
The 2nd most reported pediatric side effect, according to the same study by Dr. Sanjiv Kumra and partners, is motor dysfunction, clinically referred to as extrapyramidal condition. Around 20 percent of children and adolescents reported motor movement disruptions. Dr. Edward Freeman and Elizabeth Pulsifer-Anderson at MedicalNewsToday.com, describe several motor movement disturbances caused by neuroleptics such as Abilify. These can include neck and spinal column displacement; gait and walking conditions; irregular oral and facial motions; unmanageable finger and limb motions; eye twitching; and irregular vocalizations, breathing and swallowing. These symptoms are generally dose dependent and frequently become worse with time, and can ultimately become a more severe and chronic version called tardive dyskinesia.
Increased Suicide Risk
The United States Food and Drug Administration mandates that antidepressants, consisting of Abilify, come with a black-box warning, informing pediatric patients of an increased risk of suicidal thinking and behavior. In addition, child and teen clients with bipolar illness and schizophrenia are also at a greater risk of suicide compared to the general population. The risk of self-destructive thinking and habits considerably drops off after age 24. Parents and patients ought to be recommended about weighing the risk of suicide with the medical need for Abilify. Children on Abilify need to work with a psychological health therapist for the first a number of months to monitor any self-destructive thinking.